Norman l. Letvin

Q: What Schools Are Affiliated With Norman l. Letvin

Norman l. Letvin is affiliated with the following schools: Albert Einstein College of Medicine, Johns Hopkins University, University of Washington, University of Vienna, Duke University, Harvard University

Norman l. Letvin's AcademicInfluence.com Rankings

Norman l. Letvin

Philosophy

#4628

World Rank

#7219

Historical Rank

Logic

#2048

World Rank

#2945

Historical Rank

philosophy Degrees

Norman l. Letvin

Biology

#6082

World Rank

#8718

Historical Rank

Virology

#127

World Rank

#131

Historical Rank

Immunology

#309

World Rank

#320

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Norman l. Letvin's Degrees

Doctorate Medicine Harvard University

Why Is Norman l. Letvin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Norman l. Letvin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. (1999) (2412)
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (2007) (1258)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity (2002) (1251)
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. (1999) (966)
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. (2000) (951)
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. (1985) (946)
DNA vaccines. (1996) (894)
The isolation and characterization of the human suppressor inducer T cell subset. (1985) (829)
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes (2002) (740)
The isolation and characterization of the human helper inducer T cell subset. (1985) (700)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection (2009) (690)
Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. (1985) (630)
A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys (1996) (531)
Common Genetic Variation and the Control of HIV-1 in Humans (2009) (448)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants (2007) (419)
Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys (2006) (402)
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1 (2004) (394)
Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease (1998) (388)
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. (2013) (381)
Adaptive Immune Response of Vγ2Vδ2+ T Cells During Mycobacterial Infections (2002) (346)
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 (2009) (332)
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. (1997) (332)
Analysis of Gag-specific Cytotoxic T Lymphocytes in Simian Immunodeficiency Virus–infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I–Peptide Complex (1998) (323)
T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. (2004) (320)
Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. (1999) (319)
Vaccine protection against simian immunodeficiency virus infection. (1989) (297)
Progress in the development of an HIV-1 vaccine. (1998) (282)
Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. (1992) (279)
ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency (2002) (271)
A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis (2009) (263)
Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. (1985) (259)
New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci (1992) (258)
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques (1994) (256)
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. (1987) (254)
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys (1996) (252)
JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy (1999) (252)
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. (1989) (245)
Immunopathogenesis and immunotherapy in AIDS virus infections (2003) (243)
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys (1993) (239)
A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. (1984) (232)
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor (2014) (228)
Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. (1990) (222)
Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. (1984) (217)
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. (2000) (205)
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys (2011) (204)
Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys (1997) (202)
Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge (2006) (201)
Prospects for vaccine protection against HIV-1 infection and AIDS. (2002) (201)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. (2004) (199)
Reduction of Simian-Human Immunodeficiency Virus 89.6P Viremia in Rhesus Monkeys by Recombinant Modified Vaccinia Virus Ankara Vaccination (2001) (197)
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. (1987) (196)
Progress and obstacles in the development of an AIDS vaccine (2006) (196)
Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors (2007) (190)
Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. (2002) (183)
Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. (1991) (181)
1F7, a novel cell surface molecule, involved in helper function of CD4 cells. (1989) (180)
Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors (2004) (180)
Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys (2003) (177)
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF1 (2002) (175)
Effect of Humoral Immune Responses on Controlling Viremia during Primary Infection of Rhesus Monkeys with Simian Immunodeficiency Virus (2003) (166)
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. (1998) (163)
Mosaic Vaccines Elicit CD8+ T lymphocyte Responses in Monkeys that Confer Enhanced Immune Coverage of Diverse HIV Strains (2010) (163)
Acquired immunodeficiency syndrome in a colony of macaque monkeys. (1983) (160)
Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. (1987) (160)
A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates (2005) (159)
Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (158)
Immunization with a Modified Vaccinia Virus Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol Primes for an Anamnestic Gag-Specific Cytotoxic T-Lymphocyte Response and Is Associated with Reduction of Viremia after SIV Challenge (2000) (158)
Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. (1996) (158)
Chemical adjuvants for plasmid DNA vaccines. (2007) (156)
Simian Immunodeficiency Virus (SIV) gag DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection (2000) (155)
Simian immunodeficiency virus DNA vaccine trial in macaques (1996) (154)
Evolution of the MHC class I genes of a New World primate from ancestral homologues of human non-classical genes (1990) (149)
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys (1996) (148)
Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. (1988) (147)
Replication-Defective Adenovirus Serotype 5 Vectors Elicit Durable Cellular and Humoral Immune Responses in Nonhuman Primates (2005) (146)
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces (2009) (144)
Immunological and Virological Mechanisms of Vaccine-Mediated Protection Against SIV and HIV (2013) (143)
Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys (2004) (142)
Lymphoma in macaques: association with virus of human T lymphotrophic family. (1984) (139)
Persistent infection of macaques with simian-human immunodeficiency viruses (1995) (139)
Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques (2005) (139)
Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections (2011) (139)
Association of Prolonged Survival in HLA-A2+ Progressive Multifocal Leukoencephalopathy Patients with a CTL Response Specific for a Commonly Recognized JC Virus Epitope1 (2002) (137)
Progress toward an HIV vaccine. (2005) (134)
Multiclade Human Immunodeficiency Virus Type 1 Envelope Immunogens Elicit Broad Cellular and Humoral Immunity in Rhesus Monkeys (2005) (134)
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques (2015) (133)
Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis (1995) (131)
Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses (2005) (130)
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. (2004) (129)
Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys1 2 (2001) (128)
TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys (2010) (126)
Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys (2010) (125)
Role of CD8+ Lymphocytes in Control and Clearance of Measles Virus Infection of Rhesus Monkeys (2003) (123)
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope (2008) (122)
Prevalence of antibodies to 3 retroviruses in a captive colony of macaque monkeys (1988) (122)
Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. (2003) (122)
Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines (2003) (122)
Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization (1986) (121)
Simian Immunodeficiency Virus DNA Vaccine Trial in Macaques (1995) (121)
Fitness Costs Limit Viral Escape from Cytotoxic T Lymphocytes at a Structurally Constrained Epitope (2004) (120)
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer. (1998) (119)
Thy1+ Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes (2011) (118)
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization1 (2001) (116)
JC Virus-Specific Cytotoxic T Lymphocytes in Individuals with Progressive Multifocal Leukoencephalopathy (2001) (116)
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. (1993) (114)
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction (2003) (113)
A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells (1987) (112)
IL-15 stimulates the expansion of AIDS virus-specific CTL. (1996) (111)
Neutralizing Antibodies Elicited by Immunization of Monkeys with DNA Plasmids and Recombinant Adenoviral Vectors Expressing Human Immunodeficiency Virus Type 1 Proteins (2005) (110)
Passive Immunotherapy in Simian Immunodeficiency Virus-Infected Macaques Accelerates the Development of Neutralizing Antibodies (2004) (108)
The Envelope Glycoprotein Ectodomains Determine the Efficiency of CD4+ T Lymphocyte Depletion in Simian– Human Immunodeficiency Virus–Infected Macaques (1998) (107)
In vitro growth characteristics of simian T-lymphotropic virus type III. (1985) (105)
T lymphocyte surface antigens in primates (1983) (103)
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses (2004) (101)
Simian-Human Immunodeficiency Virus Escape from Cytotoxic T-Lymphocyte Recognition at a Structurally Constrained Epitope (2003) (101)
Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. (1994) (100)
Comparative Analysis of Cytotoxic T Lymphocytes in Lymph Nodes and Peripheral Blood of Simian Immunodeficiency Virus-Infected Rhesus Monkeys (1999) (97)
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. (2009) (96)
The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. (1990) (94)
Simian Immunodeficiency Virus (1994) (94)
Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). (1987) (94)
Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies (2011) (94)
Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36 in Patients with Proven or Possible Progressive Multifocal Leukoencephalopathy (2003) (94)
Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion (2012) (93)
Animal models for acquired immunodeficiency syndrome. (1987) (93)
Novel Adeno-Associated Virus Vector Vaccine Restricts Replication of Simian Immunodeficiency Virus in Macaques (2005) (92)
Elicitation of High-Frequency Cytotoxic T-Lymphocyte Responses against both Dominant and Subdominant Simian-Human Immunodeficiency Virus Epitopes by DNA Vaccination of Rhesus Monkeys (2001) (92)
T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian- human immunodeficiency virus (1995) (92)
HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies (2011) (91)
Phosphoantigen/IL2 Expansion and Differentiation of Vγ2Vδ2 T Cells Increase Resistance to Tuberculosis in Nonhuman Primates (2013) (90)
The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells. (1986) (90)
Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus (1999) (89)
Histopathologic changes in macaques with an acquired immunodeficiency syndrome (AIDS). (1983) (87)
Changes in Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Responsible for the Pathogenicity of a Multiply Passaged Simian-Human Immunodeficiency Virus (SHIV-HXBc2) (1999) (86)
Strategies for an HIV vaccine. (2002) (86)
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. (2008) (85)
Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. (1991) (85)
Transmission of naturally occurring lymphoma in macaque monkeys. (1983) (85)
A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques (2007) (84)
Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population (2011) (84)
Use of Major Histocompatibility Complex Class I/Peptide/β2M Tetramers To Quantitate CD8+ Cytotoxic T Lymphocytes Specific for Dominant and Nondominant Viral Epitopes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys (1999) (83)
Correlates of immune protection and the development of a human immunodeficiency virus vaccine. (2007) (83)
Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals (2004) (83)
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. (2001) (82)
Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. (1992) (81)
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys (2008) (81)
Neutralizing Antibodies in Sera from Macaques Infected with Chimeric Simian-Human Immunodeficiency Virus Containing the Envelope Glycoproteins of either a Laboratory-Adapted Variant or a Primary Isolate of Human Immunodeficiency Virus Type 1 (1998) (80)
Impairment of Gag-Specific CD8+ T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeficiency Virus mac251- and Simian-Human Immunodeficiency Virus KU2-Infected Macaques (2001) (79)
Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. (2004) (79)
A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease (1991) (79)
Membrane-Fusing Capacity of the Human Immunodeficiency Virus Envelope Proteins Determines the Efficiency of CD4+ T-Cell Depletion in Macaques Infected by a Simian-Human Immunodeficiency Virus (2001) (79)
Systemic Immunization with an ALVAC-HIV-1/Protein Boost Vaccine Strategy Protects Rhesus Macaques from CD4+ T-Cell Loss and Reduces both Systemic and Mucosal Simian-Human Immunodeficiency Virus SHIVKU2 RNA Levels (2006) (78)
Antibody-Dependent Cell-Mediated Cytotoxicity in Simian Immunodeficiency Virus-Infected Rhesus Monkeys (2011) (78)
Recruitment of different subsets of antigen‐presenting cells selectively modulates DNA vaccine‐elicited CD4+ and CD8+ T lymphocyte responses (2004) (77)
Toll-Like Receptor 7/8 (TLR7/8) and TLR9 Agonists Cooperate To Enhance HIV-1 Envelope Antibody Responses in Rhesus Macaques (2014) (77)
Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes (1992) (77)
T-cell dynamics during acute SIV infection (2003) (76)
Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. (1994) (76)
Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. (1993) (75)
A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. (1997) (74)
Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41 (2011) (74)
Utility of SHIV for testing HIV-1 vaccine candidates in macaques. (1996) (73)
Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination (2008) (72)
Cytotoxic T lymphocytes specific for the simian immunodeficiency virus (1999) (72)
DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. (2003) (71)
Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing (2010) (70)
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals. (1998) (70)
Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants (2005) (70)
Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen (2006) (69)
HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. (1997) (69)
Adaptive immune response of Vγ2Vδ2 T cells: A new paradigm (2003) (68)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. (1986) (67)
Major histocompatibility complex class I molecules of nonhuman primates (1988) (67)
Generation of CD8+ T-Cell Responses by a Recombinant Nonpathogenic Mycobacterium smegmatis Vaccine Vector Expressing Human Immunodeficiency Virus Type 1 Env (2006) (66)
A primate species with limited major histocompatibility complex class I polymorphism. (1988) (66)
Vγ2Vδ2+ T cells and anti-microbial immune responses (2003) (66)
Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses. (2004) (65)
The TCR Repertoire of an Immunodominant CD8+ T Lymphocyte Population1 (2001) (65)
JC Virus Regulatory Region Tandem Repeats in Plasma and Central Nervous System Isolates Correlate with Poor Clinical Outcome in Patients with Progressive Multifocal Leukoencephalopathy (2001) (64)
Virus-Specific Cellular Immune Correlates of Survival in Vaccinated Monkeys after Simian Immunodeficiency Virus Challenge (2006) (64)
Subsets of Memory Cytotoxic T Lymphocytes Elicited by Vaccination Influence the Efficiency of Secondary Expansion In Vivo (2004) (64)
Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review. (1990) (64)
A NATURALLY OCCURRING BONE‐MARROW‐CHIMERIC PRIMATE: I. Integrity of Its Immune System (1985) (63)
2H1--a novel antigen involved in T lymphocyte triggering. (1988) (63)
A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity (2011) (63)
Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity. (1990) (63)
Anti-HIV env immunities elicited by nucleic acid vaccines. (1997) (62)
Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome. (1986) (61)
Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. (1993) (61)
Efficiency of Cell-Free and Cell-Associated Virus in Mucosal Transmission of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus (2013) (61)
Cellular Immunity Elicited by Human Immunodeficiency Virus Type 1/ Simian Immunodeficiency Virus DNA Vaccination Does Not Augment the Sterile Protection Afforded by Passive Infusion of Neutralizing Antibodies (2003) (60)
No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys (2007) (60)
Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination (1998) (60)
Immunologic effects of whole-body ultraviolet irradiation: selective defect in splenic adherent cell function in vitro. (1980) (60)
Induction of an AIDS Virus-Related Tuberculosis-Like Disease in Macaques: a Model of Simian Immunodeficiency Virus- Mycobacterium Coinfection (2002) (60)
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates. (2017) (59)
CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. (2001) (59)
Elicitation of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Mucosal Compartments of Rhesus Monkeys by Systemic Vaccination (2002) (59)
Molecular cloning of orangutan and gibbon MHC class I cDNA. The HLA-A and -B loci diverged over 30 million years ago. (1992) (59)
Antibody-Dependent Cell-Mediated Viral Inhibition Emerges after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys Coincident with gp140-Binding Antibodies and Is Effective against Neutralization-Resistant Viruses (2011) (58)
Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model. (2006) (58)
Critical role for IL‐21 in both primary and memory anti‐viral CD8+ T‐cell responses (2010) (58)
CCL3L1 and HIV/AIDS susceptibility (2009) (57)
Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth (1990) (57)
Animal models of AIDS. (1984) (57)
Vaccine-Elicited V3 Loop-Specific Antibodies in Rhesus Monkeys and Control of a Simian-Human Immunodeficiency Virus Expressing a Primary Patient Human Immunodeficiency Virus Type 1 Isolate Envelope (2001) (56)
Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques (2002) (56)
Immune Distribution and Localization of Phosphoantigen-Specific Vγ2Vδ2 T Cells in Lymphoid and Nonlymphoid Tissues in Mycobacterium tuberculosis Infection (2007) (56)
JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy (2011) (55)
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors. (2009) (55)
Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome. (1987) (55)
Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. (1993) (55)
The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. (1995) (55)
B-lymphocyte responses to trinitrophenyl-conjugated Ficoll: requirement for T lymphocytes and Ia-bearing adherent cells. (1981) (54)
The KIR and CD94/NKG2 families of molecules in the rhesus monkey (2001) (54)
Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys (1996) (53)
Clinical Latency and Reactivation of AIDS-Related Mycobacterial Infections (2004) (53)
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. (2000) (52)
In Vivo Natural Killer Cell Depletion during Primary Simian Immunodeficiency Virus Infection in Rhesus Monkeys (2008) (52)
Magnitude and Quality of Vaccine-Elicited T-Cell Responses in the Control of Immunodeficiency Virus Replication in Rhesus Monkeys (2008) (52)
Prospects for vaccines to protect against AIDS, tuberculosis, and malaria. (2001) (52)
Contributions of Mamu-A*01 Status and TRIM5 Allele Expression, But Not CCL3L Copy Number Variation, to the Control of SIVmac251 Replication in Indian-Origin Rhesus Monkeys (2010) (52)
Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte Responses (2008) (51)
Duration of Antigen Expression In Vivo following DNA Immunization Modifies the Magnitude, Contraction, and Secondary Responses of CD8+ T Lymphocytes1 (2007) (51)
The TRIM5 Gene Modulates Penile Mucosal Acquisition of Simian Immunodeficiency Virus in Rhesus Monkeys (2011) (51)
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens. (2012) (50)
Simian Immunodeficiency Virus Evades a Dominant Epitope-Specific Cytotoxic T Lymphocyte Response Through a Mutation Resulting in the Accelerated Dissociation of Viral Peptide and MHC Class I1 (2000) (50)
EXPERIMENTAL TRANSMISSION OF MACAQUE AIDS BY MEANS OF INOCULATION OF MACAQUE LYMPHOMA TISSUE (1983) (49)
Characterization of Simian-Human Immunodeficiency Virus Envelope Glycoprotein Epitopes Recognized by Neutralizing Antibodies from Infected Monkeys (1998) (49)
Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization. (2005) (48)
Virus Inhibition Activity of Effector Memory CD8+ T Cells Determines Simian Immunodeficiency Virus Load in Vaccinated Monkeys after Vaccine Breakthrough Infection (2012) (47)
Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. (1999) (47)
Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses (2009) (47)
Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. (2001) (46)
A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02 (1994) (46)
Simian immunodeficiency virus induces expression of class II major histocompatibility complex structures on infected target cells in vitro (1987) (46)
Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights. (1990) (46)
Simian Immunodeficiency Virus Evades a Dominant Epitope-Specific Cytotoxic T Lymphocyte Response Through a Mutation Resulting in the Accelerated Dissociation of Viral Peptide and MHC Class I (2000) (45)
Vaccines against human immunodeficiency virus--progress and prospects. (1993) (45)
Immune Failure in the Absence of Profound CD4+ T-Lymphocyte Depletion in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques (2004) (45)
Antiretroviral Agents Restore Mycobacterium-Specific T-Cell Immune Responses and Facilitate Controlling a Fatal Tuberculosis-Like Disease in Macaques Coinfected with Simian Immunodeficiency Virus andMycobacterium bovis BCG (2001) (44)
Morphologic changes in lymph nodes of macaques with an immunodeficiency syndrome. (1984) (44)
Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors (2007) (44)
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. (2009) (44)
Vaccine Protection Against Functional CTL Abnormalities in Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys1 (2002) (44)
Immunodomination in the Evolution of Dominant Epitope-Specific CD8+ T Lymphocyte Responses in Simian Immunodeficiency Virus-Infected Rhesus Monkeys1 (2006) (44)
A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys. (1995) (43)
Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al (2008) (43)
Viral evolution and challenges in the development of HIV vaccines. (2002) (43)
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. (2009) (43)
Clonally Diverse CTL Response to a Dominant Viral Epitope Recognizes Potential Epitope Variants1 (2001) (42)
Retrovirus D/New England and its relation to Mason-Pfizer monkey virus (1985) (42)
Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens. (2007) (42)
Compensatory Substitutions Restore Normal Core Assembly in Simian Immunodeficiency Virus Isolates with Gag Epitope Cytotoxic T-Lymphocyte Escape Mutations (2006) (42)
Simian Immunodeficiency Virus (SIV)-Specific CD8+ T-Cell Responses in Vervet African Green Monkeys Chronically Infected with SIVagm (2008) (42)
CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro. (1989) (42)
Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate (2009) (41)
Molecular cloning of cDNA that encode MHC class I molecules from a New World primate (Saguinus oedipus). Natural selection acts at positions that may affect peptide presentation to T cells. (1990) (41)
Epitope-Specific CD8+ T Lymphocytes Cross-Recognize Mutant Simian Immunodeficiency Virus (SIV) Sequences but Fail To Contain Very Early Evolution and Eventual Fixation of Epitope Escape Mutations during SIV Infection (2011) (41)
Use of an anti‐CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques (2008) (41)
Mucosal Immunization of Lactating Female Rhesus Monkeys with a Transmitted/Founder HIV-1 Envelope Induces Strong Env-Specific IgA Antibody Responses in Breast Milk (2013) (41)
Conservation of myeloid surface antigens on primate granulocytes. (1983) (40)
Recombinant Canarypox Vaccine-Elicited CTL Specific for Dominant and Subdominant Simian Immunodeficiency Virus Epitopes in Rhesus Monkeys1 (2002) (39)
A Commonly Recognized Simian Immunodeficiency Virus Nef Epitope Presented to Cytotoxic T Lymphocytes of Indian-Origin Rhesus Monkeys by the Prevalent Major Histocompatibility Complex Class I Allele Mamu-A*02 (2001) (39)
Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids (2014) (39)
Magnitude and Diversity of Cytotoxic-T-Lymphocyte Responses Elicited by Multiepitope DNA Vaccination in Rhesus Monkeys (2003) (38)
Autologous Neutralizing Antibodies to the Transmitted/Founder Viruses Emerge Late after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys (2010) (38)
Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm. (2003) (38)
Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. (2001) (38)
T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections. (1981) (37)
Experimental infection of rhesus monkeys with type D retrovirus (1984) (37)
Vaccination of mice and nonhuman primates using HIV-gene-containing DNA. (1996) (37)
Immune biology of macaque lymphocyte populations during mycobacterial infection (2003) (37)
Inhibition of Adaptive Vγ2Vδ2+ T-Cell Responses during Active Mycobacterial Coinfection of Simian Immunodeficiency Virus SIVmac-Infected Monkeys (2003) (37)
Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. (2006) (37)
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost (2015) (37)
Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus (2005) (37)
Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus. (2000) (36)
Memory CD4+ T-Lymphocyte Loss and Dysfunction during Primary Simian Immunodeficiency Virus Infection (2007) (36)
Rapid Memory CD8+ T-Lymphocyte Induction through Priming with Recombinant Mycobacterium smegmatis (2006) (36)
Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. (2007) (36)
Herpesvirus saimiri strain 11 immortalizes a restricted marmoset T8 lymphocyte subpopulation in vitro (1986) (36)
Contribution of T-Cell Receptor Repertoire Breadth to the Dominance of Epitope-Specific CD8+ T-Lymphocyte Responses (2006) (36)
IL-21 Induces Apoptosis of Antigen-Specific CD8+ T Lymphocytes1 (2007) (36)
Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals. (2000) (36)
Intestinal Stromal Tumors in a Simian Immunodeficiency Virus-infected, Simian Retrovirus-2 Negative Rhesus Macaque (Macaca mulatta) (2005) (36)
The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. (1996) (36)
The Impact of a Boosting Immunogen on the Differentiation of Secondary Memory CD8+ T Cells (2007) (36)
Preservation of Functional Virus-Specific Memory CD8+ T Lymphocytes in Vaccinated, Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys1 (2006) (36)
Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. (1990) (35)
Loss of Ia-bearing splenic adherent cells after whole body ultraviolet irradiation. (1980) (35)
Unusually limited nucleotide sequence variation of the expressed major histocompatibility complex class I genes of a New World primate species (Saguinus oedipus) (1991) (35)
Moving Forward in HIV Vaccine Development (2009) (35)
DNA Vaccination for HIV-1 and SIV (2001) (35)
Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey (1992) (35)
Functional Equivalency of B7-1 and B7-2 for Costimulating Plasmid DNA Vaccine-Elicited CTL Responses1 (2000) (34)
Killer cell immunoglobulin‐like receptors (KIR) of the African‐origin sabaeus monkey: evidence for recombination events in the evolution of KIR (2005) (34)
Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes. (2004) (34)
Clinicopathologic Characterization of Canine Juvenile Cellulitis (1989) (34)
Evidence of NK cell dysfunction in SIV‐infected rhesus monkeys: Impairment of cytokine secretion and NKG2C/C2 expression (2006) (33)
Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity (2004) (33)
Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages (2012) (33)
In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication. (1993) (33)
Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant. (2004) (33)
Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates (2012) (33)
Robust Vaccine-Elicited Cellular Immune Responses in Breast Milk following Systemic Simian Immunodeficiency Virus DNA Prime and Live Virus Vector Boost Vaccination of Lactating Rhesus Monkeys (2010) (33)
Plasmid DNA Vaccine-Elicited Cellular Immune Responses Limit In Vivo Vaccine Antigen Expression through Fas-Mediated Apoptosis1 (2007) (33)
Immune Containment and Consequences of Measles Virus Infection in Healthy and Immunocompromised Individuals (2006) (32)
Human Immunodeficiency Virus Type 1 Envelope Epitope-Specific CD4+ T Lymphocytes in Simian/Human Immunodeficiency Virus-Infected and Vaccinated Rhesus Monkeys Detected Using a Peptide-Major Histocompatibility Complex Class II Tetramer (2000) (32)
Dysfunction of Simian Immunodeficiency Virus/Simian Human Immunodeficiency Virus-Induced IL-2 Expression by Central Memory CD4+ T Lymphocytes1 (2005) (32)
Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. (2008) (32)
Induction of Antibodies in Guinea Pigs and Rhesus Monkeys against the Human Immunodeficiency Virus Type 1 Envelope: Neutralization of Nonpathogenic and Pathogenic Primary Isolate Simian/Human Immunodeficiency Virus Strains (2000) (31)
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. (2010) (31)
Potent Simian Immunodeficiency Virus-Specific Cellular Immune Responses in the Breast Milk of Simian Immunodeficiency Virus-Infected, Lactating Rhesus Monkeys1 (2008) (31)
Limited Contribution of Mucosal IgA to Simian Immunodeficiency Virus (SIV)-Specific Neutralizing Antibody Response and Virus Envelope Evolution in Breast Milk of SIV-Infected, Lactating Rhesus Monkeys (2010) (31)
Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys. (1998) (31)
Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. (2003) (31)
Immunologic effects of whole body ultraviolet (UV) irradiation. II. Defect in splenic adherent cell antigen presentation for stimulation of T cell proliferation. (1980) (31)
An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus. (1991) (31)
Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease. (2007) (30)
JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients (2006) (30)
Animal models for the study of human immunodeficiency virus infections. (1992) (30)
Vaccine-Elicited Memory Cytotoxic T Lymphocytes Contribute to Mamu-A*01-Associated Control of Simian/Human Immunodeficiency Virus 89.6P Replication in Rhesus Monkeys (2005) (30)
Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis. (1985) (30)
B7 co‐stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination (2000) (30)
Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus (1995) (29)
Germline repertoire of the immunoglobulin VH3 family in rhesus monkeys (2000) (29)
Sequence and diversity of rhesus monkey T-cell receptor β chain genes (2004) (29)
Enhancement of plasmid DNA immunogenicity with linear polyethylenimine (2012) (29)
Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys. (1992) (29)
Global Dysfunction of CD4 T-Lymphocyte Cytokine Expression in Simian-Human Immunodeficiency Virus/SIV-Infected Monkeys Is Prevented by Vaccination (2003) (28)
Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis▿ (2006) (28)
Lymphoproliferative syndrome in an immunodeficient rhesus monkey naturally infected with an HTLV-III-like virus (STLV-III). (1986) (28)
CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses. (2008) (28)
Association of Activating KIR Copy Number Variation of NK Cells with Containment of SIV Replication in Rhesus Monkeys (2011) (28)
Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal Sites (2007) (27)
Sequence and diversity of rhesus monkey T-cell receptor beta chain genes. (1992) (27)
Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. (1995) (27)
Meningoencephalitis and Demyelination Are Pathologic Manifestations of Primary Polyomavirus Infection in Immunosuppressed Rhesus Monkeys (2004) (27)
Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection. (1995) (26)
Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response. (1991) (26)
Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio. (1987) (26)
HIV-1 envelope-specific CD4+ T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules. (1997) (26)
Centralized HIV-1 envelope immunogens and neutralizing antibodies. (2007) (25)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells. (1986) (25)
A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions (1985) (25)
Vgamma2Vdelta2+ T cells and anti-microbial immune responses. (2003) (25)
In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques. (1995) (24)
Delineation of lymphocyte subsets in lymph nodes of nonhuman primates. (1984) (24)
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes. (2015) (24)
Risks of handling HIV (1991) (24)
Contribution of CD8+ T Cells to Containment of Viral Replication and Emergence of Mutations in Mamu-A*01-Restricted Epitopes in Simian Immunodeficiency Virus-Infected Rhesus Monkeys (2008) (24)
Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate. (2004) (23)
Prior Vaccination Increases the Epitopic Breadth of the Cytotoxic T-Lymphocyte Response That Evolves in Rhesus Monkeys following a Simian-Human Immunodeficiency Virus Infection (2002) (23)
Development of Vγ2Vδ2+ T Cell Responses during Active Mycobacterial Coinfection of Simian Immunodeficiency Virus-Infected Macaques Requires Control of Viral Infection and Immune Competence of CD4+ T Cells (2004) (23)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool. (1985) (23)
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy. (2001) (23)
HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines? (2004) (23)
Detection of apoptotic cells from peripheral blood of HIV‐infected individuals using a novel monoclonal antibody (1997) (23)
Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication. (1991) (22)
Efficient Generation of Mucosal and Systemic Antigen-Specific CD8+ T-Cell Responses following Pulmonary DNA Immunization (2010) (22)
Identification of T lymphocytes in simian immunodeficiency virus encephalitis: Distribution of CD8+ T cells in association with central nervous system vessels and virus (2011) (22)
An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes. (1994) (22)
Biochemical and molecular characterization of rhesus monkey major histocompatibility complex class II DR. (1995) (22)
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. (2009) (22)
Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys. (2000) (22)
Intranasal Vaccination with the Recombinant Listeria monocytogenes ΔactA prfA* Mutant Elicits Robust Systemic and Pulmonary Cellular Responses and Secretory Mucosal IgA (2011) (22)
Genetically distinct cell populations in naturally occurring bone marrow-chimeric primates express similar MHC class I gene products. (1990) (22)
Detection of Simian Immunodeficiency Virus Gag-Specific CD8+ T Lymphocytes in Semen of Chronically Infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I-Peptide Complex (1999) (22)
Germinal Center Function in the Spleen during Simian HIV Infection in Rhesus Monkeys1 (2006) (22)
Simian Immunodeficiency Virus (SIV)-Specific CTL Are Present in Large Numbers in Livers of SIV-Infected Rhesus Monkeys1 (2000) (21)
A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4 (1995) (21)
Local replication of simian immunodeficiency virus in the breast milk compartment of chronically-infected, lactating rhesus monkeys (2010) (21)
The repertoire of cytotoxic T lymphocytes in the recognition of mutant simian immunodeficiency virus variants. (1994) (21)
A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02. (2002) (21)
Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates (2016) (21)
Genital Tract Sequestration of SIV following Acute Infection (2011) (21)
An IL-2/Ig fusion protein influences CD4+ T lymphocytes in naive and simian immunodeficiency virus-infected Rhesus monkeys. (2001) (20)
Analysis of TCRαβ Combinations used by Simian Immunodeficiency Virus-Specific CD8+ T Cells in Rhesus Monkeys: Implications for CTL Immunodominance1 (2007) (20)
Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity. (1992) (19)
Systemic and Mucosal T-Lymphocyte Activation Induced by Recombinant Adenovirus Vaccines in Rhesus Monkeys (2009) (19)
Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus. (2002) (19)
Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses (1997) (19)
Simian models for AIDS. (1987) (18)
An adherent cell lyses virus-infected targets: characterization, activation, and fine specificity of the cytotoxic cell. (1982) (18)
Surface antigen changes during B-lymphocyte activation in primates. (1984) (18)
Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. (1992) (18)
Common Tree Shrews and Primates Share Leukocyte Membrane Antigens (1984) (18)
What immunity can protect against HIV infection. (1998) (17)
HIV epitopes recognized by cytotoxic T-lymphocytes. (1991) (17)
In Vivo Anti-HIV Activity of the Heparin-Activated Serine Protease Inhibitor Antithrombin III Encapsulated in Lymph-Targeting Immunoliposomes (2012) (17)
Evaluation of CD62L expression as a marker for vaccine‐elicited memory cytotoxic T lymphocytes (2005) (17)
Animal models for AIDS. (1984) (16)
In Vivo T-Lymphocyte Activation and Transient Reduction of Viral Replication in Macaques Infected with Simian Immunodeficiency Virus (2001) (16)
Segmental exchange between MHC class I genes in a higher primate: recombination in the gorilla between the ancestor of a human non-functional gene and an A locus gene (1991) (16)
KIR2DL4 Copy Number Variation Is Associated with CD4+ T-Cell Depletion and Function of Cytokine-Producing NK Cell Subsets in SIV-Infected Mamu-A*01-Negative Rhesus Macaques (2013) (16)
Animal models of HIV and other retroviral infections (1993) (16)
Infection of baboons with human immunodeficiency virus-2 (HIV-2) (1987) (16)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin. (1988) (16)
Origins of HTLV-4 (1987) (16)
Immunologic effects of whole-body ultraviolet (uv) irradiation. III Defective splenic adherent cell function in alloantigen-stimulated T-cell proliferation. (1981) (15)
Correction: Thy1+ Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes (2011) (15)
Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys. (2003) (15)
Gender Differences in Human Immunodeficiency Virus Type 1-Specific CD8 Responses in the Reproductive Tract and Colon following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting (2004) (15)
Monitoring HIV vaccine trial participants for primary infection: studies in the SIV/macaque model (2009) (15)
Inhibition of HCV by the serpin antithrombin III (2012) (15)
Clonal Repertoires of Virus-Specific CD8+ T Lymphocytes Are Shared in Mucosal and Systemic Compartments during Chronic Simian Immunodeficiency Virus Infection in Rhesus Monkeys (2010) (14)
HIV versus the immune system: another apparent victory for the virus. (2001) (14)
Effects of Type I Interferons on the Adjuvant Properties of Plasmid Granulocyte-Macrophage Colony-Stimulating Factor In Vivo (2007) (14)
Clinical and pathologic features of an acquired immune deficiency syndrome (AIDS) in macaque monkeys. (1984) (14)
The Selection of Low Envelope Glycoprotein Reactivity to Soluble CD4 and Cold during Simian-Human Immunodeficiency Virus Infection of Rhesus Macaques (2013) (14)
T-Cell Vaccination Reduces Simian Immunodeficiency Virus Levels in Semen (2009) (14)
Rearrangement of Simian Virus 40 Regulatory Region Is Not Required for Induction of Progressive Multifocal Leukoencephalopathy in Immunosuppressed Rhesus Monkeys (2005) (14)
Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques. (2004) (14)
The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey. (1994) (13)
Gene Deletions in Mycobacterium bovis BCG Stimulate Increased CD8+ T Cell Responses (2014) (13)
Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vectors Prime for Strong Cellular Responses to Simian Immunodeficiency Virus Gag in Rhesus Macaques (2014) (13)
Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge (2007) (13)
Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease. (2004) (12)
CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro. (1990) (12)
Use of Molecular Beacons for Rapid, Real-Time, Quantitative Monitoring of Cytotoxic T-Lymphocyte Epitope Mutations in Simian Immunodeficiency Virus (2005) (12)
Immunization with lentivirus-like particles elicits a potent SIV-specific recall cytotoxic T-lymphocyte response in rhesus monkeys. (1993) (12)
Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates (2012) (12)
Molecular Determinants Regulating the Pairing of NKG2 Molecules with CD94 for Cell Surface Heterodimer Expression1 (2004) (12)
Modulation of Plasmid DNA Vaccine Antigen Clearance by Caspase 12 RNA Interference Potentiates Vaccination (2011) (12)
The CD8+ T lymphocyte response during primary SIVmac infection. (1998) (12)
Genetic Alteration of Mycobacterium smegmatis To Improve Mycobacterium-Mediated Transfer of Plasmid DNA into Mammalian Cells and DNA Immunization (2007) (12)
High Frequency of Virus-Specific B Lymphocytes in Germinal Centers of Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys (2002) (12)
Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys. (1999) (12)
Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction. (1993) (12)
Combined megaplex TCR isolation and SMART-based real-time quantitation methods for quantitating antigen-specific T cell clones in mycobacterial infection. (2006) (12)
Mutations in a Dominant Nef Epitope of Simian Immunodeficiency Virus Diminish TCR:Epitope Peptide Affinity but not Epitope Peptide:MHC Class I Binding (2011) (11)
X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens (2009) (11)
Herpesvirus ateles immortalizes in vitro a CD3+CD4+CD8+ marmoset lymphocyte with NK function. (1988) (11)
Sequence and evolution of cattle MHC class I cDNAs: concerted evolution has not taken place in cattle (2004) (11)
Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by a monoclonal antibody-based antigen capture assay. (1993) (11)
Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein (1997) (11)
Use of an animal model for the study of the role of human immunodeficiency virus 1 in the human intestine. (1992) (11)
Down‐regulation of macaque ΓΔ+ T cells in lymphoid compartments after rectal infection with SIVsmmPBj14 (2000) (11)
Dominant CD8+ T-Lymphocyte Responses Suppress Expansion of Vaccine-Elicited Subdominant T Lymphocytes in Rhesus Monkeys Challenged with Pathogenic Simian-Human Immunodeficiency Virus (2009) (11)
Transcriptional network predicts viral set point during acute HIV-1 infection (2012) (11)
Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells. (1991) (11)
Envelope Vaccination Shapes Viral Envelope Evolution following Simian Immunodeficiency Virus Infection in Rhesus Monkeys (2009) (11)
Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys. (2010) (10)
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination (2021) (10)
The Global Fund to Fight AIDS, Tuberculosis and Malaria: funding for unpopular public-health programmes (2004) (9)
Envelope Variable Region 4 Is the First Target of Neutralizing Antibodies in Early Simian Immunodeficiency Virus mac251 Infection of Rhesus Monkeys (2012) (9)
Disseminated granulomatous disease in a simian immunodeficiency virus- and bacille Calmette-Guèrin-infected rhesus monkey. (1997) (9)
Prolonged Dominance of Clonally Restricted CD4+ T Cells in Macaques Infected with Simian Immunodeficiency Viruses (2000) (9)
Virus-Specific Cytotoxic T Lymphocytes in Human Immunodeficiency Virus Type 1-Infected Chimpanzees (1999) (9)
Cytotoxic T cells in HIV and other retroviral infections (1992) (9)
T Cell Receptor V ~ Repertoire in an Acute Infection of Rhesus Monkeys with Simian Immunodeficiency Viruses and a Chimeric Simian-Human Immunodeficiency Virus (2003) (9)
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques. (2016) (9)
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. V. Evidence that humoral immune response to monoclonal antibodies and immunotoxin conjugates abrogates their cytotoxic activity. (1989) (9)
Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes. (2021) (9)
TCR Affinity Associated with Functional Differences between Dominant and Subdominant SIV Epitope-Specific CD8+ T Cells in Mamu-A*01 + Rhesus Monkeys (2014) (8)
Non-classical Natural Killer T Cells Modulate Plasmid DNA Vaccine Antigen Expression and Vaccine-elicited Immune Responses by MCP-1 Secretion after Interaction with a β2-Microglobulin-independent CD1d* (2009) (8)
Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells. (2004) (7)
Hematogenous hexamitiasis in a macaque monkey with an immunodeficiency syndrome. (1984) (7)
Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines. (1992) (7)
Nonhuman primate models for HIV vaccine development. (1992) (7)
Macaque monkey type D retrovirus replicates in vitro in a distinct subpopulation of B lymphocytes. (1987) (7)
The Magnitude and Kinetics of the Mucosal HIV-Specific CD8+ T Lymphocyte Response and Virus RNA Load in Breast Milk (2011) (7)
Flow Cytometry Sorting of Recombinant Mycobacterial Species Yields Bacterial Clones with Enhanced Insert Expression (2010) (7)
Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartments (2012) (7)
Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques. (2001) (7)
Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4+ T Cells and Antigen Duration (2015) (7)
Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections. (2016) (6)
TRIM5 modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys (2011) (6)
Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys. (2007) (6)
Two more chimpanzee Patr-A locus alleles related to the HLA-A1/A2/A11 family (1993) (6)
Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody. (1985) (6)
Macaques Immunodeficiency Virus KU 2-Infected Virus mac 251-and Simian-Human Compartments of Simian Immunodeficiency Function in Mucosal and Systemic T-Cell + Impairment of Gag-Specific CD 8 (2001) (6)
Substitutions in a Major Histocompatibility Complex Class II-Restricted Human Immunodeficiency Virus Type 1 gp120 Epitope Can Affect CD4+ T-Helper-Cell Function (1998) (6)
Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity. (2015) (6)
Expansion after epitope peptide exposure in vitro predicts cytotoxic T lymphocyte epitope dominance hierarchy in lymphocytes of vaccinated mamu-a*01+ rhesus monkeys. (2006) (6)
Conserved T Lymphocyte-Specific Antigens in Primates (1986) (6)
USE OF cDNA PROBES SPECIFIC FOR THE HUMAN MHC CLASS IIβ LOCI FOR TISSUE-TYPING NONHUMAN PRIMATES AT THEIR CLASS IIβ LOCI (1989) (6)
Vaccine-Induced CD8+ T Lymphocytes of Rhesus Monkeys Recognize Variant Forms of an HIV Epitope but Do Not Mediate Optimal Functional Activity (2011) (6)
Preservation of memory CD4(+) T lymphocytes in breast milk of lactating rhesus monkeys during acute simian immunodeficiency virus infection. (2010) (6)
SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria. (2013) (6)
Use of radiolabeled monoclonal anti-B1 antibody for B lymphocyte imaging in rhesus monkeys. (1987) (5)
Immune responses in lentivirus-infected animals. (1991) (5)
Down-regulation of macaque gammadelta + T cells in lymphoid compartments after rectal infection with SIVsmmPBj14. (2000) (5)
Syrian hamsters express diverse MHC class I gene products. (1990) (5)
MHC expression of African green monkeys of Barbados is limited in heterogeneity (1995) (4)
Clinicopathological characterization of an HIV‐2‐infected individual with two clonally unrelated primary lymphomas (2000) (4)
Development of large granular lymphocytes in owl monkeys following EBV inoculation. (1985) (4)
Plaque-forming cell responses to trinitrophenyl (TNP)-L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) in microcultures are not under conventional Ir gene control. (1981) (4)
Natural Killer cell-dependent and non-dependent anti-viral activity of 2-Cys Peroxiredoxin against HIV. (2013) (4)
Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (4)
Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections (2016) (4)
Enhanced Priming of Adaptive Immunity by Mycobacterium smegmatis Mutants with High-Level Protein Secretion (2012) (4)
Activating KIR Copy Number Variation Is Associated with Granzyme B Release by NK Cells during Primary Simian Immunodeficiency Virus Infection in Rhesus Monkeys (2012) (4)
The Development of Monoclonal Antibodies against Human Immunoregulatory T Cell Subsets: The Isolation of Human Suppressor Inducer T Cell Subset (1986) (4)
7 IL-21 Induces Apoptosis of Antigen-specific CD8+ T Lymphocytes (2007) (4)
CD8 + Lymphocyte Response in Lymph Nodes from Patients with HIV Infection1 (1992) (3)
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center (2021) (3)
Virus-specific cellular immune correlates of survival in vaccinated monkeys after SIV challenge (2006) (3)
Novel Adenovirus Vector-Based Vaccines for HIV (2005) (3)
Simian Immunodeficiency Virus (SIV)-specific CD8+ T cell responses in 1 (2008) (3)
Cross-reactive potential of human T-lymphocyte responses in HIV-1 infection. (2014) (3)
B-lymphocyte responses to trinitrophenyl-ficoll. II. Decreased splenic adherent cell function in mice expressing the xid gene. (1982) (3)
Variability in a dominant block to SIV early reverse transcription in rhesus monkey cells predicts in vivo viral replication and time to death (2010) (3)
Diverse Cross-Reactive Potential and Vβ Gene Usage of an Epitope-Specific Cytotoxic T-Lymphocyte Population in Monkeys Immunized with Diverse Human Immunodeficiency Virus Type 1 Env Immunogens (2009) (2)
Vaccination Reduces Simian-Human Immunodeficiency Virus Sequence Reversion through Enhanced Viral Control (2010) (2)
Antibody responses to trinitrophenyl (TNP)-L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) in microcultures: anti-hapten and anti-carrier responses appear to be under separable control. (1982) (2)
Immunodeficiency: An Overview (1993) (2)
This information is current as T Lymphocyte Population + CD 8 The TCR Repertoire of an Immunodominant (2001) (2)
An HIV-related virus from macaques (1987) (2)
JC Virus-Speciﬁc Cytotoxic T Lymphocytes in Individuals with Progressive Multifocal Leukoencephalopathy (2001) (2)
Active immune therapy for the treatment of HIV infections. (1992) (2)
Role for Gr-1+ Cells in the Control of High-Dose Mycobacterium bovis Recombinant BCG (2014) (2)
Use of cDNA probes specific for the human MHC class II beta loci for tissue-typing nonhuman primates at their class II beta loci. (1989) (2)
The Role of Cytotoxic T Lymphocytes in the Immunopathogenesis of SIV-Induced Disease (1993) (2)
Limited MHC class I polymorphism is not essential for bone marrow chimerism in New World primates (2005) (1)
121 Effect of Activating KIR Copy Number Variation on NK Cell Containment of SIV Replication in Rhesus Monkeys (2012) (1)
Distinct Evolutionary Pressures Underlie Diversity in Simian and (2012) (1)
The CD8 + Lymphocyte Response in Simian Immunodeficiency Virus-Infected Rhesus Monkeys (1992) (1)
Naturally occurring animal models of the acquired immune deficiency syndrome (AIDS). (1991) (1)
Amarendra Pegu than those to the CD 4 receptor Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo (2014) (1)
A vaccine that delivers rather than induces antibodies (2009) (1)
Unusual recombinant HLA-B alleles in a tribe of South American Amerindians (1992) (1)
Postbinding functions of CD4 in HIV infection. (1996) (1)
Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate (2009) (1)
Anti-Gamma Interferon Antibodies Enhance the Immunogenicity of Recombinant Adenovirus Vectors (2011) (1)
Conselho Superior Da Defensoria Pública Do Estado (2011) (1)
Vaccine protection against simian immunodeficiency virus infection ( acquired immunodeficiency syndrome / immunization / animal model / Macaca mulatto (1)
Inhibition of HCV by the serpin antithrombin III (2012) (1)
Rapid Memory CD8 (cid:1) T-Lymphocyte Induction through Priming with Recombinant Mycobacterium smegmatis (cid:1) (2006) (0)
Biodistribution of a labeled monoclonal antibody to B lymphocytes (1985) (0)
REPORTE CORTO/SHORT REPORT - PASSIVE IMMUNE GLOBULIN THERAPY AND ITS POTENTIAL FOR REDUCING VIRAL BURDEN (1995) (0)
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes (1989) (0)
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys (2009) (0)
Prevention of experimental allergic encephalo myelitis in the sjl j mouse by whole body uv irradiation (1984) (0)
The Immunobiology of HIV-1 Infection (2021) (0)
Evolution of Great Ape MHC Class I Genes (1991) (0)
Immunity to infection (1992) (0)
Neutralizing Antibodies Afforded by Passive Infusion of Does Not Augment the Sterile Protection Immunodeficiency Virus DNA Vaccination Immunodeficiency Virus Type 1 / Simian Cellular Immunity Elicited by Human (2003) (0)
Breakthrough Infection Vaccinated Monkeys after Vaccine Immunodeficiency Virus Load in T Cells Determines Simian + CD8Inhibition Activity of Effector Memory (2014) (0)
Inhibition of Adaptive V (cid:2) 2V (cid:3) 2 (cid:1) T-Cell Responses during Active Mycobacterial Coinfection of Simian Immunodeﬁciency Virus SIVmac-Infected Monkeys (2003) (0)
Hamburg , D ) B . Brew ( Darlinghurst , AUS ) 99 Evaluation of a JC virus-speci c immunoglobulin M enzyme linked immunosorbent assay (2005) (0)
ImmunizationSystemic and Mucosal CTL After Nasal Cytokine Requirements for Induction of (2001) (0)
Monkeys Immunodeficiency Virus-Infected Rhesus Abnormalities in Simian Human Vaccine Protection Against Functional CTL (2001) (0)
Corrigendum to: Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes [Virology 475 (2015) 37–45] (2015) (0)
Simian Immunodeficiency Virus Epitopes in Subdominant CTL Specific for Dominant and Recombinant Canarypox Vaccine-Elicited (2013) (0)
Immune Distribution and Localization of Phosphoantigen-Speciﬁc V (cid:2) 2V (cid:3) 2 T Cells in Lymphoid and Nonlymphoid Tissues in Mycobacterium tuberculosis Infection (cid:1) (2007) (0)
THE HB-F PROGRAM IN PRIMATE ERYTHROID PROGENITOR CELLS AND THE EFFECTS OF HYDROXYUREA ON HB-F PRODUCTION (1984) (0)
Advances in Brief Equivalent Induction of Telomerase-specific Cytotoxic T Lymphocytes from Tumor-bearing Patients and Healthy Individuals 1 (2001) (0)
CD8+ T Lymphocytes IL-21 Induces Apoptosis of Antigen-Specific (2013) (0)
Antibody-Dependent Cell-Mediated Cytotoxicity in Simian Immunodeﬁciency Virus-Infected Rhesus Monkeys (cid:1) (2011) (0)
Rationale for testing chemokine inhibitors (Virustats) for prevention of HIV-1 transmission. (2001) (0)
Identification and Functional Characteristics of T Lymphocytes (1990) (0)
This information is current as Lactating Rhesus Monkeys and Live Virus Vector Boost Vaccination of Simian Immunodeficiency Virus DNA Prime Responses in Breast Milk following Systemic Robust Vaccine-Elicited Cellular Immune (2017) (0)
Lung-targeted Plasmid DNA Vaccines Induce Potent Cellular Immune Responses (2010) (0)
Patent Number : 45 Date of Patent : 5 , 654 , 195 Aug . 5 , 1997 (2017) (0)
T-Cell Vaccination Reduces Simian Immunodeﬁciency Virus Levels in Semen (cid:1) (2009) (0)
Subject Index Vol. 43, 2000 (2001) (0)
DISEASE STATES AND VACCINES: SELECTED CASES (2003) (0)
Costimulating Plasmid DNA Vaccine-Elicited Functional Equivalency of B 7-1 and B 7-2 for Sharpe and (2000) (0)
Expression of the CD 8 ab-Heterodimer on CD 8 1 T Lymphocytes in Peripheral Blood Lymphocytes of Human Immunodeficiency Virus 2 and Human Immunodeficiency Virus 1 Individuals (1998) (0)
6 – DISEASE STATES AND VACCINES: SELECTED CASES: PART F. AIDS Vaccines: Challenges and Prospects (2003) (0)
An acutely lethal simian immunodeficiency virus stimulates expansion of Vp 7-and Vp 14-expressing T lymphocytes ( superantgen / T-cedf receptor VP repertolre / AIDS / SIVsmmPBJ 14 ) (0)
Histopathologic Changes in Maca ques With an Acquired Immunodeiciency Syndrome (AIDS) (2007) (0)
JCV-speci c cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy (2005) (0)
KIR2DL4 Copy Number Variation Is Associated with CD4 + T-Cell Depletion and 1 Function of Cytokine-Producing NK Cell Subsets in SIV-Infected Mamu-A*01 - 2 (2013) (0)
Viral Peptide and MHC Class I Resulting in the Accelerated Dissociation of Lymphocyte Response Through a Mutation Dominant Epitope-Specific Cytotoxic T Simian Immunodeficiency Virus Evades a (2000) (0)
Impairment of Gag-Speciﬁc CD8 (cid:1) T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeﬁciency Virus mac251- and Simian-Human Immunodeﬁciency Virus KU2-Infected Macaques (2001) (0)
Virus-Infected, Lactating Rhesus Monkeys the Breast Milk of Simian Immunodeficiency Virus-Specific Cellular Immune Responses in Potent Simian Immunodeficiency (2008) (0)
Contribution of CD8 (cid:1) T Cells to Containment of Viral Replication and Emergence of Mutations in Mamu-A * 01 -Restricted Epitopes in Simian Immunodeﬁciency Virus-Infected Rhesus Monkeys (cid:1) † (2008) (0)
Contribution of T-Cell Receptor Repertoire Breadth to the Dominance of Epitope-Speciﬁc CD8 (cid:1) T-Lymphocyte Responses (cid:1) (2006) (0)
HIV Envelope vaccination elicits asparagine 332 glycan-dependent antibodies that resemble broadly neutralizing antibody precursors (2017) (0)
Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C (2012) (0)
gp120 and GM-CSF Bicistronic HIV-1 DNA Vaccine Expressing T Cell Responses Elicited by a + Potent CD4 (2001) (0)
AIDS virus escape from cytotoxic T lymphocyte containment in monkeys (2003) (0)
Corrigendum: Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartments (2014) (0)
Bicistronic HIV-1 DNA Vaccine Expressing Potent CD4+ T Cell Responses Elicited by a (2013) (0)
Monkeys Immunodeficiency Virus-Infected Rhesus Peripheral Blood of Simian Lymphocytes in Lymph Nodes and Comparative Analysis of Cytotoxic T (1998) (0)
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center (2021) (0)
Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses (2012) (0)
Correction: Association of Activating KIR Copy Number Variation of NK Cells with Containment of SIV Replication in Rhesus Monkeys (2012) (0)
Epitope Peptide:MHC Class I Binding TCR:Epitope Peptide Affinity but not Simian Immunodeficiency Virus Diminish Mutations in a Dominant Nef Epitope of (2011) (0)
Invitro growthcharacteristics ofsimian T-lymphotropic virus typeIII (1985) (0)
Anticorps se fixant a une molecule cd4 a conformation modifiee, induite par fixation du virus de l'immunodeficience humaine (1995) (0)
Pre-Existing Anti-Ad5 Immunity Serotype 35 Vaccine in the Presence of Immunogenicity of Recombinant Adenovirus (2004) (0)
cell pool nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T In vivo administration of lymphocyte-specific monoclonal antibodies in (2011) (0)
B — Non-Human Primate Models for HIV-1 Infection (2000) (0)
The cellular immune response against JC virus is instrumental in the containment of progressive multifocal leukoencephalopathy (2011) (0)
MonkeysImmunodeficiency Virus Infection in Rhesus of Virus During Primary Simian Emergence of CTL Coincides with Clearance (1999) (0)
The genetic restriction of T lymphocyte—B lymphocyte interactions (1982) (0)
Administration Vaccine by Plasmid Cytokine/Ig Immune Responses to an HIV-1 DNA Augmentation and Suppression of (2010) (0)
Envelope Vaccination Shapes Viral Envelope Evolution following Simian Immunodeﬁciency Virus Infection in Rhesus Monkeys (cid:1) (2009) (0)
Sequence and Evolution of Bovine MHC Class I Genes (1991) (0)
HIV AND THE IMMUNE SYSTEM (1990) (0)
Recombinant Bacillus Calmette-Guérin vectors prime for strong cellular responses (2014) (0)
Plasmid Cytokine/Ig Administration Responses to an HIV-1 DNA Vaccine by Augmentation and Suppression of Immune (1998) (0)
The immunobiology of HIV (2007) (0)
Epitope Variants Dominant Viral Epitope Recognizes Potential Clonally Diverse CTL Response to a (2013) (0)
Immunodeficiency Virus Variants of Simian-Human Characterization of Primary Isolate-Like (1999) (0)
Epitope-Speciﬁc CD8 (cid:1) T Lymphocytes Cross-Recognize Mutant Simian Immunodeﬁciency Virus (SIV) Sequences but Fail To Contain Very Early Evolution and Eventual Fixation of Epitope Escape Mutations during SIV Infection (cid:1) † (2011) (0)
Monoclonal antibodies and immunization it. (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Norman l. Letvin?

Norman l. Letvin is affiliated with the following schools:

Norman l. Letvin's Academic­Influence.com Rankings

Norman l. Letvin's Degrees

Why Is Norman l. Letvin Influential?

Norman l. Letvin's Published Works

Published Works

What Schools Are Affiliated With Norman l. Letvin?

Norman l. Letvin's AcademicInfluence.com Rankings